Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives $34.17 Average Target Price from Brokerages
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fifteen analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and […]
31 Jul 05:58 · The Markets Daily